New diabetes guidelines urging tighter control spark debate.
Maintaining that prevailing U.S. guidelines for the treatment of diabetes are not up to 'worldwide standards,' a leading endocrinology group is pushing for clinical practice recommendations of its own. One of the group's key provisions is a call for a more aggressive target for HbA1c levels. It's a target that some experts are calling unrealistic. Get an early look at the new recommendations--and some expert feedback.
D001786:Blood Glucose / Q000032:analysis*; D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000097:blood* / Q000628:therapy; D019468:Disease Management; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007003:Hypoglycemia / Q000097:blood; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014481:United States
D001786:Blood Glucose; D006442:Glycated Hemoglobin